These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 3489642)

  • 1. Immunological activities of muramyl peptides.
    Bahr GM; Chedid L
    Fed Proc; 1986 Oct; 45(11):2541-4. PubMed ID: 3489642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Muramyl dipeptide (MDP): its origin, mechanism of action and prospects for its use].
    Castrillón LE
    Salud Publica Mex; 1987; 29(6):492-9. PubMed ID: 3125614
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunomodulation of macrophages by muramyl peptides: recent findings concerning somnogenic activity of muramyl peptides and monokine.
    Leclerc C; Chedid L
    Int J Tissue React; 1984; 6(3):215-8. PubMed ID: 6332794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target cells for immunomodulatory action of muramyl dipeptide.
    Dozmorov IM; Bagaeva LV; Kuzin II; Svirshchevskaya EV
    Biomed Sci; 1991; 2(2):193-7. PubMed ID: 1772973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of the in vivo dinitrophenyl antibody response to the DNP conjugate of L-glutamic acid60-L-alanine30-L-Tyrosine10 (GAT) polymer by a synthetic adjuvant, muramyl dipeptide (MDP): target cells for adjuvant activity and isotypic pattern of MDP-stimulated response.
    Lowy I; Theze J; Chedid L
    J Immunol; 1980 Jan; 124(1):100-4. PubMed ID: 6965289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antitumoral activation of rat peritoneal macrophages by muramyl dipeptide in vitro].
    Reisser D; Jeannin JF; Martin F
    C R Seances Acad Sci III; 1982 Nov; 295(8):485-8. PubMed ID: 6819063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-[trans-2-[[2'-(acetylamino)cyclohexyl]oxy]acetyl]-L-alanyl-D-glutamic acid: a novel immunologically active carbocyclic muramyl dipeptide analogue.
    Kikelj D; Pecar S; Kotnik V; Stalc A; Wraber-Herzog B; Simcic S; Ihan A; Klamfer L; Povsic L; Grahek R; Suhadolc E; Hocevar M; Hönig H; Rogi-Kohlenprath R
    J Med Chem; 1998 Feb; 41(4):530-9. PubMed ID: 9484503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of muramyl dipeptide (MDP)-induced T suppressor cells responsible for MDP immunosuppressive activity.
    Leclerc C; Bourgeois E; Chedid L
    Eur J Immunol; 1982 Mar; 12(3):249-52. PubMed ID: 6980118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of colony-stimulating factor from macrophages by muroctasin.
    Yamaguchi F; Akahane K; Takashi T; Tsukada W
    Arzneimittelforschung; 1988 Jul; 38(7A):983-6. PubMed ID: 3263870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The macrophage, target cell of the synthetic adjuvant muramyl dipeptide.
    Fevrier M; Birrien JL; Leclerc C; Chedid L; Liacopoulos P
    Eur J Immunol; 1978 Aug; 8(8):558-62. PubMed ID: 359336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The immunomodulating activity of new muramyl dipeptide derivatives in vitro].
    Medvedev AE; Fuks BB; Bovin NV; Zemliakov AE
    Biull Eksp Biol Med; 1992 Dec; 114(12):626-8. PubMed ID: 1292694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muramyl dipeptide and mononuclear cell supernatant induce Langhans-type cells from human monocytes.
    Mizuno K; Okamoto H; Horio T
    J Leukoc Biol; 2001 Sep; 70(3):386-94. PubMed ID: 11527988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of indomethacin on various immunopharmacological effects of muramyl dipeptide (MDP).
    Parant M; Riveau G; Chedid L
    Agents Actions Suppl; 1980; 7():33-40. PubMed ID: 6941684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effect of muramyl dipeptide in vivo and in vitro on the tumoricidal activity of rat peritoneal macrophages.
    Reisser D; Jeannin JF; Lagadec P; Martin F
    J Biol Response Mod; 1985 Oct; 4(5):460-3. PubMed ID: 4078593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage activation by mycobacterial water soluble compounds and synthetic muramyl dipeptide.
    Wahl SM; Wahl LM; McCarthy JB; Chedid L; Mergenhagen SE
    J Immunol; 1979 Jun; 122(6):2226-31. PubMed ID: 221582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopharmacology of muramyl peptides.
    Masek K
    Fed Proc; 1986 Oct; 45(11):2549-51. PubMed ID: 3758372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muramyl dipeptide-Lys stimulates the function of human dendritic cells.
    Todate A; Suda T; Kuwata H; Chida K; Nakamura H
    J Leukoc Biol; 2001 Nov; 70(5):723-9. PubMed ID: 11698491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muramyl dipeptide enhances in vitro peritoneal macrophage phagocytic activity.
    McCoy DM; Brown GL; Ausobsky JR; Polk HC
    Am Surg; 1985 Nov; 51(11):634-6. PubMed ID: 4062058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vivo effect of cyclosporine A on macrophages.
    Matsushima Y; Baba T
    J Exp Pathol; 1990; 5(2):39-48. PubMed ID: 2090798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropharmacological activities of MDP.
    Chedid L
    Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):101-3. PubMed ID: 3713369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.